Scientists are developing blood tests based on proteomics, a technology that analyzes proteins to assess organ age and overall health. This could revolutionize how individuals make daily decisions about diet, lifestyle, and medical treatments.
Proteomics offers a real-time assessment of how the body functions, potentially identifying vulnerabilities and guiding personalized interventions. Unlike genetic tests, proteomics measures the proteins produced by the body, providing a dynamic view of health.
Researchers are exploring how proteomics can detect early signs of disease and tailor interventions. Studies suggest that different dietary choices, like yogurt or white wine, may impact organ aging differently. These tests could soon become a key tool in early disease detection and prevention.
While still under development, proteomics holds promise for personalized health management. Companies like Vero are aiming to make these tests accessible to consumers, potentially for around $200. This technology could become a standard part of routine health assessments in the coming years.